Patrick Zueger

1.2k total citations · 1 hit paper
34 papers, 731 citations indexed

About

Patrick Zueger is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Patrick Zueger has authored 34 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Rheumatology, 17 papers in Hematology and 10 papers in Immunology. Recurrent topics in Patrick Zueger's work include Autoimmune and Inflammatory Disorders Research (17 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Spondyloarthritis Studies and Treatments (13 papers). Patrick Zueger is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (17 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Spondyloarthritis Studies and Treatments (13 papers). Patrick Zueger collaborates with scholars based in United States, United Kingdom and Japan. Patrick Zueger's co-authors include Aileen L. Pangan, J. Anderson, Mitsumasa Kishimoto, Iain B. McInnes, Philip J. Mease, Frank Behrens, Filip Van den Bosch, William Tillett, Marina Magrey and Joseph F. Merola and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Geriatrics Society and Annals of the Rheumatic Diseases.

In The Last Decade

Patrick Zueger

33 papers receiving 723 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

2021 182 citations Iain B. McInnes, J. Anderson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Zueger United States	13	469	395	283	79	58	34	731
P. M. Houtman Netherlands	16	483 1.0×	225 0.6×	173 0.6×	34 0.4×	59 1.0×	25	768
Maher Issa United States	19	493 1.1×	120 0.3×	182 0.6×	168 2.1×	163 2.8×	26	965
Luke Peterson United States	15	480 1.0×	970 2.5×	294 1.0×	61 0.8×	477 8.2×	59	1.3k
Jeffrey B. Shiroky Canada	12	397 0.8×	111 0.3×	142 0.5×	76 1.0×	20 0.3×	16	669
Talia M. Muram United States	11	206 0.4×	775 2.0×	116 0.4×	59 0.7×	426 7.3×	18	972
Yin You United States	17	341 0.7×	1.0k 2.6×	216 0.8×	46 0.6×	478 8.2×	34	1.2k
T. Klopsch Germany	6	444 0.9×	163 0.4×	180 0.6×	24 0.3×	12 0.2×	12	597
Ahmad Naim United States	15	194 0.4×	96 0.2×	322 1.1×	99 1.3×	21 0.4×	45	781
Kavitha Goyal United States	12	204 0.4×	828 2.1×	118 0.4×	55 0.7×	389 6.7×	22	1.0k
A Kapelle Germany	4	389 0.8×	155 0.4×	128 0.5×	29 0.4×	11 0.2×	7	503

Countries citing papers authored by Patrick Zueger

Since Specialization

Citations

This map shows the geographic impact of Patrick Zueger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Zueger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Zueger more than expected).

Fields of papers citing papers by Patrick Zueger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Zueger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Zueger. The network helps show where Patrick Zueger may publish in the future.

Co-authorship network of co-authors of Patrick Zueger

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Zueger. A scholar is included among the top collaborators of Patrick Zueger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Zueger. Patrick Zueger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wright, Grace C., et al.. (2025). Health Disparities in Rheumatology in the United States. Open Access Rheumatology Research and Reviews. Volume 17. 1–12. 1 indexed citations

Curtis, Jeffrey R., Patrick Zueger, Fenglong Xie, et al.. (2024). Wearable activity tracker study exploring rheumatoid arthritis patients’ disease activity using patient-reported outcome measures, clinical measures, and biometric sensor data (the wear study). Contemporary Clinical Trials Communications. 38. 101272–101272. 2 indexed citations

Helfgott, Simon M., et al.. (2024). Real‐World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First‐Line Tumor Necrosis Factor Inhibitor Therapy in the United States. ACR Open Rheumatology. 6(4). 179–188. 1 indexed citations

Bergman, Martin, Naijun Chen, Richard J. Thielen, & Patrick Zueger. (2023). One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib. Advances in Therapy. 40(10). 4493–4503. 7 indexed citations

Harrold, Leslie R., Patrick Zueger, W. Benjamin Nowell, et al.. (2023). A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis. Rheumatology and Therapy. 10(6). 1519–1533. 2 indexed citations

Bergman, Martin, et al.. (2022). Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry. Rheumatology and Therapy. 10(1). 187–199. 6 indexed citations

Ogdie, Alexis, Carol Mansfield, William Tillett, et al.. (2022). Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower Registry. Rheumatology and Therapy. 9(2). 735–751. 9 indexed citations

McInnes, Iain B., Koji Kato, Marina Magrey, et al.. (2021). AB0523 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS AT 56 WEEKS FROM THE SELECT-PsA 1 STUDY. Annals of the Rheumatic Diseases. 80. 1288–1289. 4 indexed citations

Strand, Vibeke, Filip Van den Bosch, Roberto Ranza, et al.. (2021). Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2. Rheumatology and Therapy. 8(4). 1827–1844. 14 indexed citations

10.

Nissen, Michael J., Burkhard Möller, Adrian Ciurea, et al.. (2021). Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors. Arthritis Research & Therapy. 23(1). 165–165. 1 indexed citations

11.

Strand, Vibeke, Philip J. Mease, Enrique R. Soriano, et al.. (2021). Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1. Rheumatology and Therapy. 8(4). 1789–1808. 20 indexed citations

12.

Mease, Philip J., Apinya Lertratanakul, J. Anderson, et al.. (2020). Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2. Annals of the Rheumatic Diseases. 80(3). 312–320. 162 indexed citations

13.

Aletaha, Daniel, Andrew J. Epstein, Martha Skup, et al.. (2019). Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study. Advances in Therapy. 36(7). 1672–1683. 38 indexed citations

14.

Zueger, Patrick, Holly M. Holmes, Gregory S. Calip, et al.. (2019). Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission. Journal of General Internal Medicine. 34(10). 2029–2037. 10 indexed citations

15.

Harrold, Leslie R., Jenny Griffith, Patrick Zueger, et al.. (2019). Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry. The Journal of Rheumatology. 47(7). 959–967. 9 indexed citations

16.

Östör, Andrew J.K., Siegfried Wassenberg, Patrick Zueger, et al.. (2018). THU0190 Clinical outcomes among rheumatoid arthritis patients receiving adalimumab who did or did not participate in the patient support program: a subanalysis of the passion study. Annals of the Rheumatic Diseases. 77. 314–315. 1 indexed citations

17.

Zueger, Patrick, Holly M. Holmes, Gregory S. Calip, et al.. (2018). Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice. Journal of the American Geriatrics Society. 66(5). 937–944. 6 indexed citations

18.

Zueger, Patrick, Norman L. Katz, & Nicholas G. Popovich. (2014). Assessing Outcomes and Perceived Benefits of a Professional Development Seminar Series. American Journal of Pharmaceutical Education. 78(8). 150–150. 8 indexed citations

19.

Zueger, Patrick, Neil M. Schultz, & Todd A. Lee. (2014). Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic Review. PharmacoEconomics. 32(11). 1079–1091. 17 indexed citations

20.

Zueger, Patrick & R Becker. (2013). The Affordability of Oncology and HIV/AIDS Technologies in Brazil Compared to the United States and Other OECD Countries. Value in Health. 16(7). A684–A684. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact